TARGETING ASTROCYTES SLOWS DISEASE PROGRESSION IN AMYOTROPHIC LATERAL SCLEROSIS
February 04, 2008
February 04, 2008
LA JOLLA, Calif., Feb. 4 -- The University of California at San Diego issued the following press release:
In what the researchers say could be promising news in the quest to find a therapy to slow the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, scientists at the University of California, San Diego (UCSD) School of Medicine have shown that targeting neuronal support cells called astrocytes sharply slows disease progression in mice.
Th . . .
In what the researchers say could be promising news in the quest to find a therapy to slow the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, scientists at the University of California, San Diego (UCSD) School of Medicine have shown that targeting neuronal support cells called astrocytes sharply slows disease progression in mice.
Th . . .